INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,575,742 | -18.0% | 87,843 | -0.4% | 0.39% | -16.5% |
| Q2 2023 | $5,583,368 | +13.2% | 88,177 | -3.2% | 0.47% | +8.8% |
| Q1 2023 | $4,932,849 | +1.1% | 91,096 | -1.2% | 0.43% | -3.2% |
| Q4 2022 | $4,877,689 | -5.0% | 92,171 | +2.4% | 0.44% | -32.7% |
| Q3 2022 | $5,137,000 | +0.2% | 89,994 | +0.2% | 0.66% | +35.8% |
| Q2 2022 | $5,128,000 | -7.5% | 89,844 | -0.8% | 0.49% | -22.5% |
| Q1 2022 | $5,542,000 | +18.9% | 90,544 | +1.7% | 0.63% | +15.9% |
| Q4 2021 | $4,661,000 | – | 89,051 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |